Literature DB >> 21617211

Heterogeneity of metalloproteinase expression in colorectal cancer - relation of molecular findings to basic morphology.

Yoshiki Kajiwara1, Hideki Ueno, Yojiro Hashiguchi, Eiji Shinto, Hideyuki Shimazaki, Hidetaka Mochizuki, Kazuo Hase.   

Abstract

AIM: To clarify the correlation between morphological features and the mRNA expression of a disintegrin and metalloproteinases (ADAMs) and matrix metalloproteinases (MMPs) in colorectal cancer.
MATERIALS AND METHODS: In 29 colorectal tumors, cancer cells were isolated by laser microdissection, and the mRNA expression of metalloproteinases was compared between the tumor center and the invasive front.
RESULTS: Regarding the central region as the standard, the mRNA levels of ADAM-12, MMP-1, -2, -7, and -9 at the invasive front were up-regulated. The degree of up-regulation was significantly higher in solid cancer nest (SCN)-positive tumors than in SCN-negative tumors for the mRNA levels of ADAM-12, MMP-2, -7, and - 9 (SCN-positive, median 5.1-, 3.9-, 9.9-, and 2.7-fold; SCN-negative 2.0-, 1.0-, 2.4-, and 0.8-fold; p<0.05, respectively).
CONCLUSION: Up-regulation of the mRNA expression of particular metalloproteinases was significantly associated with the SCN at the leading edge of colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617211

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer.

Authors:  Masato Yamadera; Eiji Shinto; Ken Nagata; Takehiro Shiraishi; Yoshiki Kajiwara; Satsuki Mochizuki; Koichi Okamoto; Yoji Kishi; Hideki Ueno
Journal:  Int J Clin Oncol       Date:  2022-01-29       Impact factor: 3.402

3.  Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.

Authors:  Marjun P Duldulao; Wendy Lee; Leanne Streja; Peiguo Chu; Wenyan Li; Zhenbin Chen; Joseph Kim; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

4.  Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer.

Authors:  H Ueno; E Shinto; Y Kajiwara; S Fukazawa; H Shimazaki; J Yamamoto; K Hase
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

Review 5.  Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known.

Authors:  Luca Reggiani Bonetti; Valeria Barresi; Stefania Bettelli; Federica Domati; Cristian Palmiere
Journal:  Diagn Pathol       Date:  2016-03-22       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.